Project 1
项目1
基本信息
- 批准号:10598771
- 负责人:
- 金额:$ 12.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS with Kaposi&aposs sarcomaAdherenceAdoptedAfricaAfrica South of the SaharaAgeAwarenessBiopsyCaringCervical Cancer ScreeningClinicClinicalCommunitiesCommunity NetworksCommunity WorkersConsentCountryCouplingCutaneousDataDetectionDiagnosisDiseaseEarly DiagnosisEarly treatmentEducationEffectivenessFosteringHIVHIV/AIDSHealthHealth PersonnelHealthcareHospitalsIncidenceInterventionKaposi SarcomaKnowledgeLesionLinkMalignant NeoplasmsMalignant neoplasm of cervix uteriMorbidity - disease rateNetwork-basedOceansOutcomePathologyPersonsPhysical ExaminationProviderRecurrenceReportingRespondentRoleSamplingServicesSiteSocial NetworkStandardizationStructureTanzaniaTeaching HospitalsTreatment outcomeUniversitiesZambiaantiretroviral therapycancer carecancer diagnosiscare providerscare systemseffectiveness evaluationempowermentexperienceimplementation strategyimprovedimproved outcomeintegrated caremortalityneoplasticpre-clinicalprogramsscale upscreeningskillstreatment center
项目摘要
Despite more than a decade of implementing universal access to antiretroviral therapy (ART) in sub-Saharan
Africa (SSA), Kaposi’s sarcoma (KS) remains the most common malignancy in people living with HIV/AIDS
(PLWH), causing significant morbidity and mortality. Compared to the US, ART implementation in SSA has not
resulted in a significant reduction of KS cases. For many PLWH in SSA, the only connection to health care is
through HIV care and treatment centers (CTC). Lack of recognition of early KS by both CTC care providers
and PLWH, and ineffective connection to diagnosis, care, and treatment when the disease presents in the
setting of HIV management at CTC may foster late presentation and ultimately, poor outcomes. Compared to
cervical cancer, where screening and early detection approaches have been successfully integrated into HIV
care for PLWH, efforts to detect, diagnose, and treat KS early are lacking. Since KS presents mostly
cutaneous, coupling KS detection to HIV management as has been done in cervical cancer for early detection
should readily improve early KS detection, definitive diagnosis, and linkage to care. As services for HIV
management are conducted through CTCs throughout SSA, these community-associated structures are the
best platform to integrate KS interventions and can be leveraged to increase early-stage presentation, early KS
diagnosis, and early treatment initiation. In this study, we will implement an integrated education package to
raise awareness and to impart the skills for early KS detection and diagnosis to PLWH, health care providers,
and community workers. This package includes recurrent educational sessions at CTCs in order to enhance
detection, diagnosis, and to initiate KS treatment early to improve outcomes of PLWH. It will also include a
social network-based strategy to enhance the sustainability of such an implementation program. We
hypothesize that an integrated care approach will increase the number and proportion of PLWH detected with
early KS, thereby improving early KS diagnosis and treatment to improve KS outcomes. There are 3 Specific
Aims. 1) Implement KS education, early detection, diagnosis, and linkage to care program at CTCs in Tanzania
and Zambia. 2) To enhance and sustain early KS detection, diagnosis, and linkage to care program through a
community network-based respondent-driven sampling (RDS) strategy in Tanzania and Zambia. 3) To
evaluate the effectiveness of integrating early KS detection, diagnosis, and RDS strategy in existing HIV care
services for PLWH in Tanzania and Zambia. Together, this will determine whether sensitization of providers
and PLWH to a combined HIV care and early KS detection approach is efficacious and viable in the setting.
This study is significant, as it will increase the proportion of PLWH examined for early KS detection, diagnosed,
and linked to cancer care. It will also focus on empowering and equipping providers and PLWH to make more
informed health decisions. This can be readily adopted and scaled up in Tanzania and Zambia, and
subsequently in other SSA to facilitate early KS diagnosis and treatment.
尽管在撒哈拉以南地区实施普遍获得抗逆转录病毒治疗(ART)已有十多年
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E HAGENSEE其他文献
MICHAEL E HAGENSEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E HAGENSEE', 18)}}的其他基金
Interaction of EBV and HPV in the development of cervical dysplasia in HIV+ women
EBV 和 HPV 在 HIV 女性宫颈发育不良中的相互作用
- 批准号:
7814393 - 财政年份:2009
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
8230703 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7495472 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7780076 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
8034749 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Interaction of EBV and HPV in the Development of Cervical Dysplasia in HIV+ Women
EBV 和 HPV 的相互作用在 HIV 女性宫颈发育不良的发展中
- 批准号:
7616766 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
ORAL HPV INFECTION IN HIV CO-INFECTED INDIVIDUALS
HIV 合并感染者的口腔 HPV 感染
- 批准号:
7376285 - 财政年份:2005
- 资助金额:
$ 12.65万 - 项目类别:
ORAL HPV INFECTION IN HIV CO-INFECTED INDIVIDUALS
HIV 合并感染者的口腔 HPV 感染
- 批准号:
7204039 - 财政年份:2004
- 资助金额:
$ 12.65万 - 项目类别:
相似海外基金
The antitumor effect of histone deacetylase inhibitor against multidrug-resistant Ewing' s sarcoma cells
组蛋白脱乙酰酶抑制剂对多重耐药尤文氏肉瘤细胞的抗肿瘤作用
- 批准号:
21791409 - 财政年份:2009
- 资助金额:
$ 12.65万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
NON-HUMAN PRIMATE MODEL OF KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS INFECTION
卡波西肉瘤相关疱疹病毒感染的非人灵长类动物模型
- 批准号:
7715514 - 财政年份:2008
- 资助金额:
$ 12.65万 - 项目类别:
Role of viral microRNAs in Kaposi´s Sarcoma-associated Herpesvirus (KSHV) infection and KSHV-associated Disease
病毒 microRNA 在卡波西肉瘤相关疱疹病毒 (KSHV) 感染和 KSHV 相关疾病中的作用
- 批准号:
37904962 - 财政年份:2007
- 资助金额:
$ 12.65万 - 项目类别:
Research Grants
KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS GENE EXPRESSION
卡波西肉瘤相关疱疹病毒基因表达
- 批准号:
7349564 - 财政年份:2006
- 资助金额:
$ 12.65万 - 项目类别:
KAPOSI?S SARCOMA-ASSOCIATED HERPESVIRUS K1 SIGNALOSOME
卡波西肉瘤相关疱疹病毒 K1 信号体
- 批准号:
7349565 - 财政年份:2006
- 资助金额:
$ 12.65万 - 项目类别: